Skip to main content
. 2013 Sep 17;4:19–26. doi: 10.2147/POR.S51838

Figure 4.

Figure 4

Proportion of participants expressing an autoinjector preference, both overall and by attribute.

Notes: P < 0.05 for the difference between autoinjectors, both overall and by attribute. *Novartis Pharma AG, Basel, Switzerland; **Bayer Schering Pharma AG, Berlin, Germany.